Pharmaceutical

Gilead and Genesis partner to create novel therapies using AI

Gilead Sciences has partnered with Genesis Therapeutics to discover and develop new small molecule therapies using AI.

Sep 12, 2024 - 04:00
Gilead and Genesis partner to create novel therapies using AI
Gilead Sciences has partnered with Genesis Therapeutics to discover and develop new small molecule therapies using AI.
Read the original article

Tags:

Previous Article

Sanofi inaugurates vaccine plant in Neuville-sur-Saône, France

Next Article

Prodrugs and patents: Enhancing therapy adherence and reducing side effects 

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

First targeted alpha therapy wins FDA breakthrough device designation

First targeted alpha therapy wins FDA breakthrough devi...

Feb 12, 2024

STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access

STAT+: Pharmalittle: U.S. to impose inflation penalties...

Dec 15, 2023

Michael J. Fox on how far Parkinson’s research has come: ‘We don’t want to be celebrated. We want to get things done’

Michael J. Fox on how far Parkinson’s research has come...

Oct 20, 2023